Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Yunji Announces First Quarter 2023 Unaudited Financial Results 2023-06-02 18:00
Tarena to Report First Quarter 2023 Financial Results on June 12, 2023 2023-06-02 18:00
Zhihu Inc. to Hold Annual General Meeting on June 30, 2023 2023-06-02 17:56
IMOU launches new outdoor & indoor camera Cruiser 2 & Rex 3D with the latest A.I. algorithms 2023-06-02 17:09
Xinhua Silk Road: C. China's Sanmenxia City spurs new vitality for high-quality development through cultural events 2023-06-02 16:23
Shennongjia: 'Mini Switzerland' in China 2023-06-02 16:03
515 Fosun Family Day Sets Off Consumption Boom With Cumulative Sales of Nearly RMB10 Billion 2023-06-02 15:57
Beyond What You See: Media, students take green trip to Beijing's Tongzhou district 2023-06-02 15:38
133rd Canton Fair Online Brings Together Quality Products to Foster Children's Healthy Development 2023-06-02 15:24
The 14th International Infrastructure Investment and Construction Forum Kicks Off in Macao 2023-06-02 14:24
LONGi unveils 2022 Sustainability Report in Beijing, disclosing the company's actions and achievements in ESG 2023-06-02 14:07
LONGi unveils 2022 Sustainability Report in Beijing, disclosing the company's actions and achievements in ESG 2023-06-02 13:46
NMPA accepted Akeso's ebronucimab (PCSK9) marketing application in two cardiovascular indications 2023-06-02 11:43
Sunport Power Brings Its Latest Full Black Flexible PV Module Based On MBC2.0 Technology to SNEC 2023 2023-06-02 10:54
HeyGears Launches First Professional Desktop 3D Printer for Consumers 2023-06-02 10:46
ZETRIX DEPLOYS W3C-COMPLIANT DIGITAL IDENTITY SERVICE ('DIS') AS XINGHUO INTERNATIONAL SUPERNODE GOES LIVE 2023-06-02 10:00
Top Performer: Huasun's Himalaya HJT Modules Have Passed Rigorous PVEL Reliability Testing 2023-06-02 09:16
Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China 2023-06-02 08:00
EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally 2023-06-02 00:10
Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment 2023-06-02 00:06
1 375 376 377 378 379 3272